
Ovarian Cancer — Year in Review Series on Relevant New Datasets and Advances
Oncology Today with Dr Neil Love
00:00
Pembrolizumab + weekly paclitaxel (B96) results
Nicoletta summarizes B96 design rationale, PFS and OS benefits and the role of metronomic weekly paclitaxel with IO.
Play episode from 24:35
Transcript


